Neudle.com: tumor necrosis factor

Differential
(Click to cross reference)

abciximab

abdominal reflex, absent

abortion, spontaneous

acetylcholine receptor

acetylcholine receptor antibody

acoustic neurinoma

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome, congenital

acquired immunodeficiency syndrome, infants and children

acyclovir

adalimumab

aducanumab

advances in neurology

adverse drug reaction

Alzheimer's disease, early onset

Alzheimer's disease, treatment of

amblyopia, toxic

AMPA receptor antibodies

amyloid

amyloid beta protein

amyloid beta protein antibodies

amyloid deposition

amyloid plaques

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

anemia

aneurysm

aneurysm, intracranial

aneurysm, intracranial, treatment of

angiitis, granulomatous of CNS

angiotensin-converting enzyme

ankylosing spondylitis

anti GQ1b IgG antibody

anti JC virus antibodies

anti Yo antibody

anti-amyloid therapy

anticonvulsants

antineutrophil cytoplasmic autoantibodies

anxiety

aphasia

apolipoprotein E

apoliprotein E, plasma level

arachnoiditis

area postrema

area postrema syndrome

arteriopathy

arteritides

arteritis, temporal

arteritis, temporal, recurrent

atherosclerosis, accelerated

atherosclerosis, premature

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune encephalopathy

autonomic dysfunction

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection, CNS

basal ganglia

basal ganglia, hemorrhage

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

behavioral disorder, acute

blood dyscrasias, neurologic findings with

bone marrow transplantation

brachial plexus injury

brachial plexus neuropathy

brain atrophy

brain biopsy

brain biopsy, false negative

brain biopsy, negative

calcification, intracranial

calcitonin gene related peptide

calcitonin gene-related peptide receptor blocker

cancer associated myopathy

cancer, cerebrovascular accident complicating patients with

cardiac surgery, neurologic complications with

cardiac transplantation

cardiotoxicity

carotid artery atherosclerosis

carotid artery disease

CAT scan, contrast enhanced, subepend.

CAT scan, emission, abnormal

CAT scan, orbits

catatonia

cauda equina

cauda equina, enhancement

cauda equina, lesion of

cavernous hemangioma

cavernous sinus

cavernous sinus, metastasis to

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellitis

cerebellitis, autoimmune

cerebellum, disease of

cerebral arteries

cerebral atherosclerosis

cerebral cortex

cerebral cortical atrophy

cerebral edema

cerebral edema, vasogenic

cerebral hypersensitivity, delayed

cerebral infarction, hemorrhagic

cerebral ischemia

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS tumors

cerebrospinal fluid, cytology

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, infancy and childhood

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, pathogenesis

cerebrovascular disease, risk factors in

chairbound

chemosis

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

chromosomal abnormality

cigarette smoking

cladribine

Clinical Pathologic Conference(C.P.C.)

cluster headache

cognition

coinfection

collapsin response mediator protein 5 IgG

confusional state, acute

congenital malformation

congestive heart failure

contraindications

controversies in neurology

cop 1

corneal dystrophy

Cornelia de Lange syndrome

coronavirus

corpus callosum, lesion of

C-reactive protein, elevated

critical care unit

cyclophosphamide

cyclosporine

cyst, epidermoid of CNS

cytokines

cytomegalovirus infection

dementia, rapidly progressive

dementia, reversible

dementia, treatment of

demyelinating disease

dentate nuclei

dentate nuclei, lesion of

dermatomyositis

developmental abnormality of brain

developmental milestones

developmental milestones, loss of

developmental retardation

diabetes insipidus

diagnostic criteria

diarrhea

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

diurnal variation

dizziness

donanemab

DPPX, antibodies, encephalitis

drug abuse

drug holiday

drug induced neurologic disorders

drug withdrawal

dysarthria

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, facial

dysphagia

dyspnea

dysthyroid ocularmyopathy

electroencephalogram, abnormalities of

electron microscopy

emotional lability

encephalitis

encephalitis, acanthamoeba

encephalitis, amebic

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, viral

encephalopathy

encephalopathy, anoxic

encephalopathy, delayed

eosinophilia

ependymoma

epidemiology of neurology

Epstein-Barr virus, negative

eptinezumab

erenumab

etanercept

evidence-based research

exophthalmus

extralimbic encephalitis

extraocular muscle enlargement

eye movement, painful

eye, pain in

face, numbness of

facial nerve palsy

facial nerve palsy, bilateral

facial pain

faciobrachial dystonic seizure

fluorescein angiography

fremanezumab

frexalimab

fumarate

fungal infection, CNS

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

glioblastoma multiforme(astrocytoma Gr.III)

glioma

glioma, low-grade

glutamic acid decarboxylase, antibody

GM1 ganglioside antibodies

granulomatosis with polyangiitis

granulomatous disease

granulomatous hypophysitis

Graves ophthalmopathy

growth retardation

Guillain Barre syndrome

Guillain Barre syndrome, etiology of

gyral hemorrhage

hallucination

hallucination, olfactory

head circumference

headache

headache, children

headache, drug induced

headache, episodic

headache, preventive treatment

headache, prophylaxis

headache, recurrent

headache, severe

headache, sudden onset of

headache, treatment of

hemiplegia, progressive

hemoglobinuria

hemolysis

hemosiderosis of CNS, superficial

hepatic failure

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex virus infection, immunosuppressed patient

herpes zoster

hiccoughs

highly active antiretroviral therapy

hippocampus

HLA

Hodgkin's disease

human immunodeficiency virus type 1

hydrocephalus

hypercalcemia

hypercoagulable state

hyperekplexia

hypereosinophilic syndrome(HES)

hypersensitivity reaction

hypertension

hyperthyroidism

hypertrophic intracranial pachymeningitis

hypothalamus, lesion of

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

IgG4-related disease

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

intellectual deterioration

intelligence quotient

internal carotid artery

intracerebral hemorrhage

intracerebral hemorrhage, causes of

intracerebral hemorrhage, differential diagnosis of

intracerebral hemorrhage, lobar

intracerebral hemorrhage, multiple

intracerebral hemorrhage, small

intracranial pressure, increased

intrathecal chemotherapy

JC virus cerebellar granule cell neuronopathy

JC virus encephalopathy

Klinefelter's syndrome

lactic dehydrogenase(LDH)

laminar necrosis, cortical

laquinimod

lecanemab

leucine rich glioma inactivated 1 antibodies

leukemia, neurologic findings assoc.with

leukoencephalopathy

leukoencephalopathy, toxic

levamisole

level of consciousness, decreased

life expectancy

limbic encephalitis

lipoprotein receptor-related protein 4

listeria monocytogenes

lymph node biopsy

lymphadenopathy

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

lymphomatoid granulomatosis

lymphopenia

malaria

malaria, cerebral

malformation, CNS, congenital

mediastinum, lymph-node biopsy

mediastinum, mass of

medication withdrawal

medulla oblongata

medulla oblongata, lesion of

medulloblastoma

melanoma, malignant

memory, defect of recent

memory, impairment of

meningeal enhancement

meningitis, bacterial

meningitis, basilar

meningitis, carcinomatous

meningitis, children

meningitis, chronic

meningitis, CSF findings in

meningitis, diagnosis

meningitis, drug induced

meningitis, iatrogenic

meningitis, listeria monocytogenes

meningitis, lymphomatous

meningitis, neurologic aspects and complications of

meningitis, neutrophilic

meningitis, noninfectious

meningitis, pneumococcal

meningitis, recurrent

meningitis, TB

meningitis, treatment of

meningoencephalitis

meningoencephalopathy

meningomyelitis

mental retardation

mental status, abnormal

microhemorrhage, intracerebral

microscopic polyangiitis

microsporidia

microsurgery

middle cerebellar peduncle

middle cerebellar peduncle, lesion

middle cerebral artery

migraine

migraine, children

migraine, chronic

migraine, intractable

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mild cognitive impairment

mimics

misdiagnosis

molecular genetics

monoclonal antibodies

monoclonal antibodies for tumor cells in CSF

monoclonal gammopathy

mononeuropathy

mononeuropathy multiplex

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, incidental finding

MRI, magnetization transfer sequence

MRI, mass effect on

MRI, negative

MRI, nodular enhancement

MRI, spinal cord, increased intramedullary cord signal

MRI, susceptibility weighted

MRS

multinucleated giant cell

multiple sclerosis

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, etiology of

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, prognosis

multiple sclerosis, relapsing

multiple sclerosis, treatment of

muscle weakness, proximal

MuSK antibodies

mutism

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, drug induced

myasthenia gravis, drug resistant

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myelitis, longitudinal

myelitis, transverse

myelitis, transverse, recurrent

natalizumab, discontinuation

necrotizing vasculitis

negative

neoplasm, intracranial

neoplasm, intracranial with metastasis extracranially

neoplasm, intracranial-incidence and epidemiology of

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, metastatic to CNS-differential diagnosis of

neoplasm, metastatic to CNS-multiple

neoplasm, metastatic to CNS-origin of

neoplasm, metastatic to CNS-prognosis of

neoplasm, metastatic to CNS-recurrent

neoplasm, metastatic to CNS-treatment of

neoplasm, metastatic to CNS-work up for

neoplasm, pituitary

neoplasm, primary intracerebral

neoplasm, primary intracerebral, reoperation

neoplasm, primary intracranial-treatment of

neoplasm, primary of CNS

neoplasm, primary of CNS-children

neoplasm, primary of CNS-classification

neoplasm, primary of CNS-differential diagnosis

neoplasm, primary of CNS-familial occurrence

neoplasm, primary of CNS-incidence of

neoplasm, primary of CNS-recurrent

neoplasm, primary of CNS-surgical treatment of

neoplasm, primary of CNS-survival

neoplasm, primary of CNS-treatment of

nerve biopsy

neurexin-3 alpha antibodies

neuroendocrinology

neurofibromatosis 2

neurofilament light chain protein

neurogenic stunned myocardium

neurologic complications

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic symptoms

neurolymphomatosis

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuronal cell surface antigen

neuronal migration disorder

neuroophthalmology

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, sensory

neuropathy, toxic

neuropathy, vasculitic, systemic

nonsteroidal anti-inflammatory drug

nortriptyline

ocrelizumab

oculovestibular reflex

ofatumumab

old age, neurology of

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

optic neuropathy

optic neuropathy, toxic

oral contraceptives

orbit, lesions of

organ transplantation

pain

pain, abdominal

paraneoplastic cerebellar degeneration

parasitic infection

parasitic infection, CNS

paresthesias

paroxysmal nocturnal hemoglobinuria

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

pituitary stalk, enlarged

pituitary, adenoma

plasmapheresis

plasmapheresis, complications of

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

pleocytosis of cerebrospinal fluid, neutrophilic

pneumonia

POEMS syndrome

polymerase chain reaction

polymerase chain reaction, false negative

polymyalgia rheumatica

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

pontine hemorrhage

post transplant lymphoproliferative disease

posterior leukoencephalopathy syndrome

postoperative neurologic complications

postpartum

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

preclinical

pregnancy, neurologic complications in

pretectal syndrome

prevention of neurologic disorders

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protozoan infection

psoriasis

psoriatic arthritis

psychiatric problems in neurologic disorders

psychological testing

psychological testing, children

pulmonary infiltrates

radiation encephalopathy, delayed

radiation necrosis

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radiation therapy, total body

radiation vasculopathy

radiation, ionizing

radiation, ionizing, intrauterine

rapidly fatal neurologic illness

rapidly progressing neurologic illness

remote effect of cancer on the nervous system

remternetug

renal transplantation

rheumatoid arthritis, neurologic complications of

rimegepant

risk factors

risk factors, modification

risk stratification

risk-benefit assessment

sedimentation rate, elevated

seizure

seizure, focal

seizure, intractable

seizure, psychomotor-temporal lobe

serologic testing

serologic testing, false negative

seronegative

seropositive

serotonin agonist

severe acute respiratory syndrome

shared decision making

shoulder, pain in

skin, lesions in neurologic disorders

sleep pathology and physiology

somnolence

speech disorder

speech disorder, childhood

spinal cord

spinal cord, lesion of

splenic-vein thrombosis

splenomegaly

stem cell transplantation

stereotaxic surgery

steroid

steroid responsive encephalitis

steroid sparing therapy

steroid therapy, CNS treatment and complications with

stiff joints

stillbirth

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

subarachnoid hemorrhage

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of-bilateral

tissue plasminogen activator, intravenous

tocilizumab

toxoplasmosis, acquired

toxoplasmosis, CNS

TRAILBLAZER-ALZ trial

transient ischemic attack

treatment of neurologic disorder

treatment resistant

tremor

trigeminovascular system

triptans

tuberculosis

tumor necrosis factor

tumor necrosis factor inhibitor

unconsciousness

urinary incontinence

uveitis

vaccination, neurologic complications with

vaccine

vagus nerve stimulation

varicella zoster virus

varicella zoster virus, encephalitis

varicella zoster virus, vasculopathy

vascular endothelial growth factor

ventricular assist device

vomiting, intractable

walking, difficulty with

water channel antibodies

weakness

weakness, fatiguable

weakness, focal

weakness, generalized

weakness, unilateral

weight loss

white matter disease

white matter disease, subcortical

workup

zilucoplan

Showing articles 100 to 150 of 6378 << Previous Next >>

Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas are Associated with Improved Survival Compared with Matched Controls
AJNR 33:1763-1770, Mong, S.,et al, 2012

Fatal Varicella-Zoster Virus Vasculopathy Associated with Adalimumab Therapy
Arch Neurol 69:1193-1196, Baek, W.,et al, 2012

PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012

Long-lasting Treatment Effect of Rituximab in MuSK Myasthenia
Neurol 78:189-193, Diaz-Manera,J.,et al, 2012

Natalizumab-Associated PML Identified in the Presymptomatic Phase Using MRI Surveillance
Neurol 78:507-508, Blair,N.F.,et al, 2012

Fatal PML Associated with Efalizumab Therapy
Neurol 78:458-467, Schwab,N.,et al, 2012

Treatment of Behcets Disease
UpToDate, Jan, Smith, E.L. & Yazici, Y., 2012

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

Clinicopathologic Conference, Limbic Encephaitis with Antibodies to Leucine - Rich Glioma - inactivated 1 (LGI 1).
NEJM 365:1825-1833, Case 34-2011, 2011

Hypereosinophilia in Patients with Multiple Sclerosis Treated with Natalizumab
Neurol 77:1561-1564, Abbas, M.,et al, 2011

Multiple Sclerosis-Quenching the Flames of Inflammation
Lancet 378:1759-1760, , 2011

Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011

Evidence-based Guideline: Clinical Evaluation and Treatment of Transverse Myelitis
Neurol 77:2128-2134, Scott, T.F.,et al, 2011

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma
Neurol 76:929-930, Batchelor,T.T.,et al, 2011

Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Report of 13 Cases and Review of the Literature
JNNP 82:306-308, Benedetti,L.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Use and monitoring of low dose rituximab in myasthenia gravis
JNNP 82:659-663, Blum, S., et al, 2011

Late onset autism and anti-NMDA-receptor encephalitis
Lancet 378:98;378, Creten, C.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Ischemic Stroke and Transient Ischemic Attack After Head and Neck Radiotherapy
Stroke 42:2410-2418, Plummer, C.,et al, 2011

Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies in a Child A Treatable Condition?
Arch Neurol 68:1065-1068, Korff, C.M.,et al, 2011

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
Arch Neurol 68:1156-1164, Clifford, D.B.,et al, 2011

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Neurosacrcoidosis: Presentations and Management
Neurologist 16:2-15, Terushkin,V.,et al, 2010

Primary Central Nervous System Lymphoma
Arch Neurol 67:291-297, Gerstner,E.R. &Batchelor,T.T., 2010

Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis
Neurol 74:521-523, Gutwinski,S.,et al, 2010

Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010

Response to Immunotherapy in a 20-Month-Old Boy With Anti-NMDA Receptor Encephalitis
Neurol 74:1550-1551, Wong-Kisiel,L.C., et al, 2010

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Treatment of Refractory Neurosarcoidosis with Infliximab
JNNP 81:241-246, Santos,E., et al, 2010

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

A Case of Neurosarcoidosis Successfully Treated with Rituximab
Neurol 75:568-570, Bomprezzi,R., et al, 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Safety and Efficacy of Natalizumab in Children With Multiple Sclerosis
Neurol 75:912-917, Ghezzi,A.,et al, 2010

Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010

Acute Toxoplasmosis Infection in a Patient with Ankylosing Spondylitis Treated with Adalimumab: A Case Report
Reumatismo 62:283-285, Azevedo V.F., et al, 2010

Primary Central Nervous System Post-Transplantation Lymphoproliferative Disorder
CANCER 16:863-870, Cavaliere, R.,et al, 2010

Treatment of CNS Sarcoidosis with Infliximab and Mycophenolate Mofetil
Neurol 72:337-340, Morovan,M. &Segal,B.M., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009

Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Showing articles 100 to 150 of 6378 << Previous Next >>